Ipilimumab/nivolumabHypophysitis: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1965卷 / 1期

关键词：

D O I：

10.1007/s40278-023-43226-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：258 / 258

相关论文

共 50 条

[21] Ipilimumab/levothyroxine sodium/nivolumabHypophysitis, adrenal insufficiency and syncopal episode: case report
[J]. Reactions Weekly, 2017, 1652 (1) : 159 - 159
[22] Ipilimumab/nivolumabHypophysitis and cerebral amyloid angiopathy-related inflammation: case report
[J]. Reactions Weekly, 2021, 1872 (1) : 267 - 267
[23] Ipilimumab/nivolumabHypophysitis and adrenal insufficiency following off label use: case report
[J]. Reactions Weekly, 2019, 1781 (1) : 207 - 207
[24] NivolumabHypophysitis: case report
[J]. Reactions Weekly, 2017, 1641 (1) : 198 - 198
[25] NivolumabHypophysitis: case report
[J]. Reactions Weekly, 2020, 1787 (1) : 394 - 394
[26] Ipilimumab/nivolumabHypophysitis and thyroiditis
[J]. Reactions Weekly, 2023, 1985 (1) : 274 - 274
[27] Ipilimumab/nivolumabHypophysitis and hypopituitarism
[J]. Reactions Weekly, 2023, 1986 (1) : 223 - 223
[28] Ipilimumab/nivolumabHypophysitis and adrenalitis
[J]. Reactions Weekly, 2024, 2006 (1) : 343 - 343
[29] NivolumabHypophysitis: case report
[J]. Reactions Weekly, 2018, 1714 (1) : 300 - 300
[30] Ipilimumab/nivolumabHypophysitis leading to adrenal insufficiency and acute colonic pseudo-obstruction: case report
[J]. Reactions Weekly, 2023, 1986 (1) : 224 - 224

← 1 2 3 4 5 →